Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Gultekin O; Department of Medical Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey.; Aydin V
Subjects: Drugs, Generic*/Drugs, Generic*/Drugs, Generic*/therapeutic use ; Drugs, Generic*/Drugs, Generic*/Drugs, Generic*/economics ; Antidepressive Agents*/Antidepressive Agents*/Antidepressive Agents*/therapeutic use
-
Source:
Primary health care research & development [Prim Health Care Res Dev] 2024 Sep 20; Vol. 25, pp. e40. Date of Electronic Publication: 2024 Sep 20.Publisher: Cambridge University Press Country of Publication: England NLM ID: 100897390 Publication Model: Electronic Cited
Record details
Subjects: Policy* ; Drugs, Generic*; Humans
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2023; Vol. 51 (S1), pp. 76-91. Date of Electronic Publication: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print-Electronic
Record details
-
Authors :
Beall RF; Reed F. Beall, Ph.D., is an Assistant Professor at the Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada. He is also affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Jonathan J. Darrow, S.J.D., J.D., M.B.A., is affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Aaron S. Kesselheim, M.D., J.D., M.P.H., is affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Darrow JJ
Subjects: Forecasting*; Drugs, Generic/Drugs, Generic/Drugs, Generic/*economics ; Health Care Sector/Health Care Sector/Health Care Sector/*trends
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2019 Mar; Vol. 47 (1), pp. 177-182.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:
Record details
-
Authors :
Beall RF; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.; Quinn AE
Subjects: Economic Competition*; Drugs, Generic/Drugs, Generic/Drugs, Generic/*economics ; Orphan Drug Production/Orphan Drug Production/Orphan Drug Production/*economics
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2020 Dec; Vol. 48 (4), pp. 789-795.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:
Record details
-
Authors :
Haffajee RL; Rebecca L. Haffajee, J.D., Ph.D., M.P.H., is a Policy Researcher at RAND Corporation and an Adjunct Assistant Professor in the Department of Health Management and Policy at the University of Michigan. She received her J.D. from Harvard Law School, Cambridge, Massachusetts, and her M.P.H. from the Harvard T.H. Chan School of Public Health, Boston, Massachusetts, both in 2006. She received her Ph.D. in Health Policy (in evaluative sciences and statistics) from Harvard University, Cambridge, Massachusetts in 2016. Her research is focused in the behavioral health and pharmaceutical policy areas, evaluating policies such as mental health/substance use parity and laws intended to curb opioid addiction and misuse. Richard G. Frank, Ph.D., is the Margaret T. Morris Professor of Health Economics in the Department of Health Care Policy at Harvard Medical School. From 2009 to 2011, he served as the deputy assistant secretary for planning and evaluation at the U.S. Department of Health and Human Services (DHHS), directing the office of Disability, Aging and Long-Term Care Policy. From 2013 to 2014, he served as a Special Advisor to the Office of the Secretary at the DHHS, and from 2014 to 2016 he served as Assistant Secretary for Planning and Evaluation in the DHHS. His research is focused on the economics of mental health and substance abuse care, long-term care financing policy, health care competition, implementation of health reform and disability policy.; Frank RG
Subjects: Legislation, Drug*; Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/*economics ; Drugs, Generic/Drugs, Generic/Drugs, Generic/*economics
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2019 Dec; Vol. 47 (4_suppl), pp. 43-53.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:
Record details
